Drugs & Clinical Trials | By April 01, 2008 | By Karen Vieira, MBA, PhDcloseKaren Vieira, MBA, PhD Name: Karen Vieira
Site: http://karenvieira.com
See All Articles by Author (25)
About: Dr. Vieira holds a PhD and MBA. She has written about medical research, medical procedures, food ingredients, herbal remedies, pharmaceutical drugs, condo construction, real estate and computer consulting to mention a few. | 0 Comments

New Anti-Cancer Drug for Aggressive Brain Tumors

Researchers are constantly trying to find new drugs or forms of therapy that can be used to treat cancer. Quite often when a possible treatment is discovered, being allowed to test a drug or other experimental cancer treatment at a clinical level is difficult. For example, after an anti-carcinogenic drug has been thoroughly tested at the experimental level it is necessary to test it in humans to analyze factors such as the drug’s anti-tumor activity, its ability to interact with a specific target, and to discover which patients are more likely to benefit from the drug. These types of early clinical trials are the key in the successful implementation of effective anti-tumor drugs and therapies. Read more →